The clinical characteristics of spinocerebellar ataxia 36: A study of 2121 Japanese ataxia patients

Movement Disorders

Volumn 27, Issue 9, 2012, Pages 1158-1163

  Sugihara, Katsunobu ^a   Maruyama, Hirofumi ^a   Morino, Hiroyuki ^a   Miyamoto, Ryosuke ^a   Ueno, Hiroki ^b   Matsumoto, Masayasu ^b   Kaji, Ryuji ^c   Kitaguchi, Hiroshi ^d   Yukitake, Motohiro ^e   Higashi, Yasuto ^f   Nishinaka, Kazuto ^g   Oda, Masaya ^h   Izumi, Yuishin ^c   Kawakami, Hideshi ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

^d KURASHIKI CENTRAL HOSPITAL   (Japan)

^e SAGA UNIVERSITY   (Japan)

^f Himeji Central Hospital   (Japan)

^g SUMITOMO HOSPITAL   (Japan)

^h Vihara Hananosato Hospital   (Japan)

Author keywords

Age of onset; Cerebellar atrophy; Hyperreflexia; Regional distribution; SCA36

Indexed keywords

PROTEIN; SPINOCEREBELLAR ATAXIA 36 PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATAXIA; AUTOSOMAL DOMINANT INHERITANCE; BRAIN STEM; CEREBELLUM ATROPHY; CLINICAL FEATURE; DISEASE CLASSIFICATION; DISEASE COURSE; DYSARTHRIA; DYSPHAGIA; EXOPHTHALMOS; FAMILY HISTORY; FEMALE; GENE MUTATION; HUMAN; HYPERREFLEXIA; JAPANESE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NYSTAGMUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPINOCEREBELLAR ATAXIA 36; SPINOCEREBELLAR DEGENERATION; SYMPTOM; TONGUE DISEASE;

ADULT; AGE OF ONSET; ASIAN CONTINENTAL ANCESTRY GROUP; BRAIN STEM; CEREBELLUM; DISEASE PROGRESSION; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; POLYMERASE CHAIN REACTION; SPINOCEREBELLAR ATAXIAS; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 84864741860     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25092     Document Type: Article

References (13)

1. Durr A. Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond. Lancet Neurol 2010; 9: 885-894.
2. Kobayashi H, Abe K, Matsuura T, et al. Expansion of intronic GGCCTG hexanucleotide repeat in NOP56 causes SCA36, a type of spinocerebellar ataxia accompanied by motor neuron involvement. Am J Hum Genet 2011; 89: 121-130.
3. Garcia-Murias M, Quintans B, Arias M, et al. 'Costa da Morte' ataxia is spinocerebellar ataxia 36: clinical and genetic characterization. Brain 2012; 135: 1423-1435.
4. Maruyama H, Izumi Y, Morino H, et al. Difference in disease-free survival curve and regional distribution according to subtype of spinocerebellar ataxia: a study of 1, 286 Japanese patients. Am J Med Genet 2002; 114: 578-583.
5. Ohta Y, Hayashi T, Nagai M, et al. Two cases of spinocerebellar ataxia accompanied by involvement of the skeletal motor neuron system and bulbar palsy. Intern Med. 2007; 46: 751-755.
6. Maruyama H, Kawakami H, Kohriyama T, et al. CAG repeat length and disease duration in Machado-Joseph disease: a new clinical classification. J Neurol Sci 1997; 152: 166-171.
7. Eichler L, Bellenberg B, Hahn HK, Köster O, Schöls L, Lukas C. Quantitative assessment of brain stem and cerebellar atrophy in spinocerebellar ataxia types 3 and 6: impact on clinical status. Am J Neuroradiol 2011; 32: 890-897.
8. Tsuji S, Onodera O, Goto J, et al. Sporadic ataxias in Japan-a population-based epidemiological study. Cerebellum 2008; 7: 189-197.
9. Abe K, Ikeda Y, Kurata T, et al. Cognitive and affective impairments of a novel SCA/MND crossroad mutation Asidan. Eur J Neurol. 2012 [Epub ahead of print].
10. Lafontaine DLJ, Tollervey D. Synthesis and assembly of the box C+D small nucleolar RNPs. Mol Cell Biol 2000; 20: 2650-2659.
11. Gautier T, Berges T, Tollervey D, Hurt E. Nuclear KKE/D repeat proteins Nop56p and Nop58p interact with Nop1p and are required for ribosome biogenesis. Mol Cell Biol 1997; 17: 7088-7098.
12. Sasaki H, Yabe I, Tashiro K. The hereditary spinocerebellar ataxias in Japan. Cytogenet Genome Res 2003; 100: 198-205.
13. Matsuyama Z, Kawakami H, Maruyama H, et al. Molecular features of the CAG repeats of spinocerebellar ataxia 6 (SCA6). Hum Mol Genet 1997; 6: 1283-1287.